Patients with APS were further stratified (a) according to clinical phenotype: into thrombotic (venous and/or arterial) and PM patients, and (b) according to aPL status (single, double triple aPL positive). The gene discussed is FASLG; the disease is autoimmune polyendocrinopathy.